Whole Genome Sequencing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently published an extensive report on the global Whole Genome Sequencing (WGS) Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

Whole Genome Sequencing Market Size (2024E): USD 1.5 Bn
Projected Market Value (2031F): USD 6.7 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 20.3%

Whole Genome Sequencing Market - Report Scope:

The Whole Genome Sequencing (WGS) Market encompasses a range of sequencing technologies used to decode the entire genetic blueprint of organisms. WGS has gained traction due to its role in precision medicine, clinical diagnostics, and genomic research. The technique captures chromosomal DNA, mitochondrial DNA, and in plants, chloroplast DNA, making it the most comprehensive form of genetic analysis. Its broad applications in diagnosing rare genetic disorders, cancer, and congenital diseases have propelled its demand. The market for WGS is expected to grow rapidly, driven by advancements in sequencing technologies and a growing emphasis on personalized medicine.

Market Growth Drivers:

The global Whole Genome Sequencing (WGS) Market is driven by several key factors:

Expanding Applications in Precision Medicine: WGS is increasingly used in precision medicine, offering personalized healthcare solutions by tailoring treatments to individual genetic profiles. It plays a crucial role in oncology, identifying genetic mutations in tumors and guiding targeted therapies for better patient outcomes.
Technological Advancements: Improvements in next-generation sequencing (NGS) technologies have reduced the cost and time required for sequencing. This has made WGS accessible to a wider audience in both research and clinical settings. The cost of sequencing has dropped significantly, from nearly $100 million in the early 2000s to below $1,000 by 2023, spurring wider adoption.
Growing Application in Clinical Diagnostics: WGS is increasingly utilized in diagnosing rare genetic disorders, prenatal screening, and pharmacogenomics, where understanding an individual's genetic makeup helps predict responses to treatments. This expanded application in healthcare is driving market growth.

Market Restraints:

The Whole Genome Sequencing Market faces several challenges:

High Cost of Sequencing Equipment: Despite the reduction in sequencing costs, the initial investment for sequencing instruments remains high, limiting adoption in smaller laboratories and emerging markets.
Data Management Challenges: WGS generates vast amounts of data, requiring advanced bioinformatics tools and data storage solutions. This presents a barrier to entry for institutions without the necessary infrastructure.
Regulatory Barriers: The use of WGS in clinical settings must comply with stringent regulatory standards, particularly regarding data privacy and the ethical use of genetic information. These regulatory requirements can slow down the adoption of WGS in certain regions.

Market Opportunities:

The Whole Genome Sequencing Market offers significant growth potential due to:

Growing Demand for Personalized Medicine: As precision medicine becomes more prevalent, WGS will be increasingly adopted in healthcare to provide tailored treatment solutions, especially in oncology and rare genetic diseases.
Rising Use of WGS in Research and Development: The integration of WGS data with other omics data (e.g., proteomics, transcriptomics) is expected to create a more comprehensive understanding of biological systems and diseases, providing opportunities for deeper insights into complex conditions.
Home-Based Genetic Testing Kits: With advancements in direct-to-consumer genetic testing, there is an opportunity for WGS companies to develop home-based kits, making genome sequencing more accessible to consumers for health management and wellness.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Whole Genome Sequencing Market globally?
How is WGS being applied in precision medicine and clinical diagnostics?
What technological advancements are shaping the competitive landscape of the Whole Genome Sequencing Market?
Who are the key players in the Whole Genome Sequencing Market, and what strategies are they employing to stay competitive?
What are the emerging trends and future prospects in the global Whole Genome Sequencing Market?

Competitive Intelligence and Business Strategy:

Leading players in the Whole Genome Sequencing Market are focusing on innovation, product differentiation, and strategic partnerships. Companies are investing in research and development to improve sequencing technologies and develop consumables that cater to evolving NGS platforms. Collaborations with research institutes and healthcare providers are helping these companies expand their market reach. Additionally, as the demand for personalized medicine grows, companies are focusing on consumer education and targeted marketing strategies to drive product adoption.

Key Market Players

Thermo Fisher Scientific, Inc
Danaher Corporation
Illumina, Inc
QIAGEN N.V.
Merck KGaA
Eurofins Scientific
Siemens Healthineers
Macrogens, Inc
Bio-Rad Laboratories, Inc
Agilent Technologies, Inc
F. Hoffmann-La Roche Ltd.

Whole Genome Sequencing Market Segmentation

By Product

Instruments
Consumables
Services

By Type

Large Whole Genome Sequencing
Small Whole Genome Sequencing

By Workflow

Pre-sequencing
Sequencing
Data Analysis

By Region

North America
Latin America
Europe
South Asia & Oceania
East Asia
The Middle East & Africa

Product Code: PMRREP34746

1. Executive Summary

1.1. Global Whole Genome Sequencing Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Technology Assessment
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2031

4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences

5. Global Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

5.1. Key Highlights
- 5.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
- 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
5.3. Global Whole Genome Sequencing Market Outlook: Product
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
- 5.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
  - 5.3.3.1. Instruments
  - 5.3.3.2. Consumables
  - 5.3.3.3. Services
5.4. Market Attractiveness Analysis: Product
5.5. Global Whole Genome Sequencing Market Outlook: Type
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2023
- 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
  - 5.5.3.1. Large Whole Genome Sequencing
  - 5.5.3.2. Small Whole Genome Sequencing
5.6. Market Attractiveness Analysis: Type
5.7. Global Whole Genome Sequencing Market Outlook: Workflow
- 5.7.1. Introduction / Key Findings
- 5.7.2. Historical Market Size (US$ Bn) Analysis, By Workflow, 2019-2023
- 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
  - 5.7.3.1. Pre-sequencing
  - 5.7.3.2. Sequencing
  - 5.7.3.3. Data Analysis
5.8. Market Attractiveness Analysis: Workflow

6. Global Whole Genome Sequencing Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
6.3. Current Market Size (US$ Bn) (Units) Analysis and Forecast, By Region, 2024-2031
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 7.3.1. By Country
- 7.3.2. By Product
- 7.3.3. By Type
- 7.3.4. By Workflow
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 7.4.1. U.S.
- 7.4.2. Canada
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 7.5.1. Instruments
- 7.5.2. Consumables
- 7.5.3. Services
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
- 7.6.1. Large Whole Genome Sequencing
- 7.6.2. Small Whole Genome Sequencing
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
- 7.7.1. Pre-sequencing
- 7.7.2. Sequencing
- 7.7.3. Data Analysis
7.8. Market Attractiveness Analysis

8. Europe Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 8.3.1. By Country
- 8.3.2. By Product
- 8.3.3. By Type
- 8.3.4. By Workflow
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. U.K.
- 8.4.4. Italy
- 8.4.5. Spain
- 8.4.6. Russia
- 8.4.7. Turkey
- 8.4.8. Rest of Europe
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 8.5.1. Instruments
- 8.5.2. Consumables
- 8.5.3. Services
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
- 8.6.1. Large Whole Genome Sequencing
- 8.6.2. Small Whole Genome Sequencing
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
- 8.7.1. Pre-sequencing
- 8.7.2. Sequencing
- 8.7.3. Data Analysis
8.8. Market Attractiveness Analysis

9. East Asia Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By Type
- 9.3.4. By Workflow
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. South Korea
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 9.5.1. Instruments
- 9.5.2. Consumables
- 9.5.3. Services
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
- 9.6.1. Large Whole Genome Sequencing
- 9.6.2. Small Whole Genome Sequencing
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
- 9.7.1. Pre-sequencing
- 9.7.2. Sequencing
- 9.7.3. Data Analysis
9.8. Market Attractiveness Analysis

10. South Asia & Oceania Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Type
- 10.3.4. By Workflow
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 10.4.1. India
- 10.4.2. Southeast Asia
- 10.4.3. ANZ
- 10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 10.5.1. Instruments
- 10.5.2. Consumables
- 10.5.3. Services
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
- 10.6.1. Large Whole Genome Sequencing
- 10.6.2. Small Whole Genome Sequencing
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
- 10.7.1. Pre-sequencing
- 10.7.2. Sequencing
- 10.7.3. Data Analysis
10.8. Market Attractiveness Analysis

11. Latin America Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 11.3.1. By Country
- 11.3.2. By Product
- 11.3.3. By Type
- 11.3.4. By Workflow
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 11.4.1. Brazil
- 11.4.2. Mexico
- 11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 11.5.1. Instruments
- 11.5.2. Consumables
- 11.5.3. Services
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
- 11.6.1. Large Whole Genome Sequencing
- 11.6.2. Small Whole Genome Sequencing
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
- 11.7.1. Pre-sequencing
- 11.7.2. Sequencing
- 11.7.3. Data Analysis
11.8. Market Attractiveness Analysis

12. Middle East & Africa Whole Genome Sequencing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
- 12.3.1. By Country
- 12.3.2. By Product
- 12.3.3. By Type
- 12.3.4. By Workflow
12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
- 12.4.1. GCC Countries
- 12.4.2. Egypt
- 12.4.3. South Africa
- 12.4.4. Northern Africa
- 12.4.5. Rest of Middle East & Africa
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
- 12.5.1. Instruments
- 12.5.2. Consumables
- 12.5.3. Services
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024-2031
- 12.6.1. Large Whole Genome Sequencing
- 12.6.2. Small Whole Genome Sequencing
12.7. Current Market Size (US$ Bn) Analysis and Forecast, By Workflow, 2024-2031
- 12.7.1. Pre-sequencing
- 12.7.2. Sequencing
- 12.7.3. Data Analysis
12.8. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2023
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping by Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Thermo Fisher Scientific, Inc
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Products
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Danaher Corporation
- 13.3.3. Illumina, Inc
- 13.3.4. QIAGEN N.V.
- 13.3.5. Merck KGaA
- 13.3.6. Eurofins Scientific
- 13.3.7. Siemens Healthineers
- 13.3.8. Macrogens, Inc
- 13.3.9. Bio-Rad Laboratories, Inc
- 13.3.10. Agilent Technologies, Inc
- 13.3.11. F. Hoffmann-La Roche Ltd.

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations